English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  52808001    線上人數 :  574
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"shih j y"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 631-655 / 1137 (共46頁)
<< < 21 22 23 24 25 26 27 28 29 30 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2020-08-12T06:34:34Z Expression of notch gene and its impact on survival of patients with resectable non-small cell lung cancer CHONG-JEN YU; Chen C.-Y.;Chen Y.-Y.;Hsieh M.-S.;Ho C.-C.;Chen K.-Y.;Shih J.-Y.;Chong-Jen Yu; Chen C.-Y.; Chen Y.-Y.; Hsieh M.-S.; Ho C.-C.; Chen K.-Y.; Shih J.-Y.
臺大學術典藏 2020-08-12T06:34:29Z Real-world data on prognostic factors for overall survival in EGFR mutation-positive advanced non-small cell lung cancer patients treated with first-line gefitinib Chen J.-S.; Lin Z.-Z.; Lin C.-C.; Yang J.C.H.; CHONG-JEN YU; Chen K.-Y.; Shih J.-Y.; Ho C.-C.; Liao W.-Y.; Yao Z.-H.; Yao Z.-H.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Shih J.-Y.;Chen J.-S.;Lin Z.-Z.;Lin C.-C.;Yang J.C.H.;Chong-Jen Yu
臺大學術典藏 2020-08-12T06:34:19Z Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non–small-cell lung cancer patients Ho C.-C.; Chen K.-Y.; Shih J.-Y.; Chen J.-S.; Lin Z.-Z.; Lin C.-C.; Yang J.C.-H.; CHONG-JEN YU; Liao W.-Y.; Yao Z.-H.; Yao Z.-H.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Shih J.-Y.;Chen J.-S.;Lin Z.-Z.;Lin C.-C.;Yang J.C.-H.;Chong-Jen Yu
臺大學術典藏 2020-08-12T06:34:19Z A rare epidermal growth factor receptor H773L/V774M compound mutation in advanced non-small-cell lung cancer with poor response to epidermal growth factor receptor tyrosine kinase inhibitor Yang C.-Y.; CHONG-JEN YU; Chen L.-C.;Shih J.-Y.;Chong-Jen Yu;Yang C.-Y.; Chen L.-C.; Shih J.-Y.
臺大學術典藏 2020-08-12T06:34:19Z Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations Lin Y.-T.;Chen J.-S.;Liao W.-Y.;Ho C.-C.;Hsu C.-L.;Yang C.-Y.;Chen K.-Y.;Lee J.-H.;Lin Z.-Z.;Shih J.-Y.;Yang J.C.-H.;Chong-Jen Yu; Ho C.-C.; Hsu C.-L.; Yang C.-Y.; Chen K.-Y.; Lee J.-H.; Lin Z.-Z.; Shih J.-Y.; Yang J.C.-H.; CHONG-JEN YU; Lin Y.-T.; Chen J.-S.; Liao W.-Y.
臺大學術典藏 2020-08-12T06:34:15Z Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors Hsu C.-C.; Wu C.-T.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Yang C.-Y.; Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Chong-Jen Yu; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; CHONG-JEN YU
臺大學術典藏 2020-08-12T06:34:13Z Clinical factors associated with treatment toxicity of pemetrexed plus platinum in elderly patients with non-small cell lung cancer Chen C.-Y.;Chen K.-Y.;Shih J.-Y.;Chong-Jen Yu; Chen C.-Y.; Chen K.-Y.; Shih J.-Y.; CHONG-JEN YU
臺大學術典藏 2020-08-12T06:34:11Z Fucosyltransferase 4 shapes oncogenic glycoproteome to drive metastasis of lung adenocarcinoma Lu H.-H.;Lin S.-Y.;Weng R.R.;Juan Y.-H.;Chen Y.-W.;Hou H.-H.;Hung Z.-C.;Oswita G.A.;Huang Y.-J.;Guu S.-Y.;Khoo K.-H.;Shih J.-Y.;Chong-Jen Yu;Tsai H.-C.; Lu H.-H.; Lin S.-Y.; Weng R.R.; Juan Y.-H.; Chen Y.-W.; Hou H.-H.; Hung Z.-C.; Oswita G.A.; Huang Y.-J.; Guu S.-Y.; Khoo K.-H.; Shih J.-Y.; CHONG-JEN YU; Tsai H.-C.
臺大學術典藏 2020-08-12T06:34:10Z Complex EGFR mutations with secondary T790M mutation confer shorter osimertinib progression-free survival and overall survival in advanced non-small cell lung cancer Liu Y.-N.; CHONG-JEN YU; Shih J.-Y.; Lin Y.-T.;Tsai T.-H.;Wu S.-G.;Liu Y.-N.;Chong-Jen Yu;Shih J.-Y.; Lin Y.-T.; Tsai T.-H.; Wu S.-G.
臺大學術典藏 2020-08-12T02:50:46Z Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysis Shih J.-Y.; CHAO-CHI HO; Yu K.-L.; Chen L.-Y.;Molina-Vila M.A.;Ruan S.-Y.;Su K.-Y.;Liao W.-Y.;Yu K.-L.;Chao-Chi Ho;Shih J.-Y.;Yu C.-J.;Yang J.C.H.;Rosell R.;Yang P.-C.; Chen L.-Y.; Molina-Vila M.A.; Ruan S.-Y.; Su K.-Y.; Liao W.-Y.; Yu C.-J.; Yang J.C.H.; Rosell R.; Yang P.-C.
臺大學術典藏 2020-08-12T02:50:43Z Multiple Acquired Resistance Mutations of the ALK Tyrosine Kinase Domain?after Sequential Use of ALK Inhibitors Wang H.-Y.; CHAO-CHI HO; Shih J.-Y.
臺大學術典藏 2020-08-12T02:50:43Z Expression of notch gene and its impact on survival of patients with resectable non-small cell lung cancer Chen C.-Y.; Chen Y.-Y.; Hsieh M.-S.; CHAO-CHI HO; Chen K.-Y.; Shih J.-Y.; Yu C.-J.; Chen C.-Y.;Chen Y.-Y.;Hsieh M.-S.;Chao-Chi Ho;Chen K.-Y.;Shih J.-Y.;Yu C.-J.
臺大學術典藏 2020-08-12T02:50:43Z Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Osimertinib Chao-Chi Ho;Liao W.-Y.;Lin C.-A.;Shih J.-Y.;Yu C.-J.;Chih-Hsin Yang J.; CHAO-CHI HO; Liao W.-Y.; Lin C.-A.; Shih J.-Y.; Yu C.-J.; Chih-Hsin Yang J.
臺大學術典藏 2020-08-12T02:50:43Z Outcomes of cancer therapy administered to treatment-na?ve lung cancer patients in the intensive care unit Yu C.-J.; Shih J.-Y.; Chen Y.-F.; Lin J.-W.; CHAO-CHI HO; Yang C.-Y.; Chang C.-H.; Huang T.-M.; Chen C.-Y.; Chen K.-Y.; Chen Y.-F.;Lin J.-W.;Chao-Chi Ho;Yang C.-Y.;Chang C.-H.;Huang T.-M.;Chen C.-Y.;Chen K.-Y.;Shih J.-Y.;Yu C.-J.
臺大學術典藏 2020-08-12T02:50:42Z Real-world data on prognostic factors for overall survival in EGFR mutation-positive advanced non-small cell lung cancer patients treated with first-line gefitinib Lin C.-C.; Yang J.C.H.; Yu C.-J.; Lin Z.-Z.; Chen J.-S.; Yao Z.-H.; Liao W.-Y.; CHAO-CHI HO; Chen K.-Y.; Shih J.-Y.; Yao Z.-H.;Liao W.-Y.;Chao-Chi Ho;Chen K.-Y.;Shih J.-Y.;Chen J.-S.;Lin Z.-Z.;Lin C.-C.;Yang J.C.H.;Yu C.-J.
臺大學術典藏 2020-08-12T02:50:42Z Astrocyte-elevated gene-1 confers resistance to pemetrexed in non-small cell lung cancer by upregulating thymidylate synthase expression Chen C.-Y.;Chen Y.-Y.;Chen J.J.W.;Chen K.-Y.;Chao-Chi Ho;Shih J.-Y.;Chang Y.-L.;Yu C.-J.;Yang P.-C.; Chen C.-Y.; Chen Y.-Y.; Chen J.J.W.; Chen K.-Y.; CHAO-CHI HO; Shih J.-Y.; Chang Y.-L.; Yu C.-J.; Yang P.-C.
臺大學術典藏 2020-08-12T02:50:41Z Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan Lin S.-Y.;Yang C.-Y.;Liao B.-C.;Chao-Chi Ho;Liao W.-Y.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Hsu W.-H.;Su K.-Y.;Chang Y.-L.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.;Yu C.-J.; Lin S.-Y.; Yang C.-Y.; Liao B.-C.; CHAO-CHI HO; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J.
臺大學術典藏 2020-08-12T02:50:40Z Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study Lin C.-C.;Shih J.-Y.;Yu C.-J.;Chao-Chi Ho;Liao W.-Y.;Lee J.-H.;Tsai T.-H.;Su K.-Y.;Hsieh M.-S.;Chang Y.-L.;Bai Y.-Y.;Huang D.D.-R.;Thress K.S.;Yang J.C.-H.; Lin C.-C.; Shih J.-Y.; Yu C.-J.; CHAO-CHI HO; Liao W.-Y.; Lee J.-H.; Tsai T.-H.; Su K.-Y.; Hsieh M.-S.; Chang Y.-L.; Bai Y.-Y.; Huang D.D.-R.; Thress K.S.; Yang J.C.-H.
臺大學術典藏 2020-08-12T02:50:40Z Epidermal growth factor receptor mutation predicts favorable outcomes in non-small cell lung cancer patients with brain metastases treated with stereotactic radiosurgery Yang W.-C.; Xiao F.; Shih J.-Y.; CHAO-CHI HO; Chen Y.-F.; Tseng H.-M.; Chen K.-Y.; Liao W.-Y.; Yu C.-J.; Yang J.C.-H.; Kuo S.-H.; Cheng J.C.-H.; Yang P.-C.; Hsu F.-M.; Yang W.-C.;Xiao F.;Shih J.-Y.;Chao-Chi Ho;Chen Y.-F.;Tseng H.-M.;Chen K.-Y.;Liao W.-Y.;Yu C.-J.;Yang J.C.-H.;Kuo S.-H.;Cheng J.C.-H.;Yang P.-C.;Hsu F.-M.
臺大學術典藏 2020-08-12T02:50:39Z Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum Liao W.-Y.;Chao-Chi Ho;Tsai T.-H.;Chen K.-Y.;Shih J.-Y.;Yu C.-J.; Liao W.-Y.; CHAO-CHI HO; Tsai T.-H.; Chen K.-Y.; Shih J.-Y.; Yu C.-J.
臺大學術典藏 2020-08-12T02:50:39Z Outcomes of research biopsies in clinical trials of EGFR mutation-positive non-small cell lung cancer patients pretreated with EGFR-tyrosine kinase inhibitors Liao B.-C.;Bai Y.-Y.;Lee J.-H.;Lin C.-C.;Lin S.-Y.;Lee Y.-F.;Chao-Chi Ho;Shih J.-Y.;Chang Y.-C.;Yu C.-J.;Chih-Hsin Yang J.;Yang P.-C.; Liao B.-C.; Bai Y.-Y.; Lee J.-H.; Lin C.-C.; Lin S.-Y.; Lee Y.-F.; CHAO-CHI HO; Shih J.-Y.; Chang Y.-C.; Yu C.-J.; Chih-Hsin Yang J.; Yang P.-C.
臺大學術典藏 2020-08-12T02:50:39Z Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study Shih J.-Y.; Ko J.-C.; CHAO-CHI HO; Liang S.-K.;Lee M.-R.;Liao W.-Y.;Chao-Chi Ho;Ko J.-C.;Shih J.-Y.; Liang S.-K.; Lee M.-R.; Liao W.-Y.
臺大學術典藏 2020-08-12T02:50:39Z Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non–Small-cell Lung Cancer Patients Lee J.-H.; Lin C.-C.; Liao W.-Y.; CHAO-CHI HO; Shih J.-Y.; Yu C.-J.; Yang J.C.-H.; Wu T.-H.; Hsiue E.H.-C.; Wu T.-H.;Hsiue E.H.-C.;Lee J.-H.;Lin C.-C.;Liao W.-Y.;Chao-Chi Ho;Shih J.-Y.;Yu C.-J.;Yang J.C.-H.
臺大學術典藏 2020-08-12T02:50:38Z The value of radial endobronchial ultrasound-guided bronchial brushing in peripheral non-squamous non-small cell lung cancer Shih J.-Y.; Hsu C.-L.; Lin C.-K.; Liao W.-Y.; CHAO-CHI HO; Yu K.-L.;Tsai T.-H.;Chao-Chi Ho;Liao W.-Y.;Lin C.-K.;Hsu C.-L.;Shih J.-Y.; Yu K.-L.; Tsai T.-H.
臺大學術典藏 2020-08-12T02:50:37Z Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations Yu C.-J.; Yang C.-Y.; Chen K.-Y.; Lee J.-H.; Lin Z.-Z.; Shih J.-Y.; Yang J.C.-H.; Hsu C.-L.; CHAO-CHI HO; Liao W.-Y.; Chen J.-S.; Lin Y.-T.; Lin Y.-T.;Chen J.-S.;Liao W.-Y.;Chao-Chi Ho;Hsu C.-L.;Yang C.-Y.;Chen K.-Y.;Lee J.-H.;Lin Z.-Z.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.

顯示項目 631-655 / 1137 (共46頁)
<< < 21 22 23 24 25 26 27 28 29 30 > >>
每頁顯示[10|25|50]項目